ChengDu Sheng Nuo Biotec (688117.SH) controlling shareholder intends to increase its stake in the company by 40-50 million yuan.
Sheng Nuo Biology (688117.SH) announced that the controlling shareholder, Sichuan Sainuo Investment Co., Ltd., plans to increase its shareholding in the company through the Shanghai Stock Exchange's system-allowed method (centralized bidding) within 12 months from the date of disclosure of the plan. The planned amount of increase is not less than 40 million yuan and not more than 50 million yuan, with funding sources from its own funds and self-raised funds (including specialized loans for stock increase).
ChengDu Sheng Nuo Biotec (688117.SH) announced that the controlling shareholder Sichuan Sainuo Investment Co., Ltd. plans to increase its holdings of the company's shares within 12 months from the date of the disclosure of the plan. The shares will be acquired through the Shanghai Stock Exchange system (centralized bidding) with a planned increase of no less than 40 million yuan and not exceeding 50 million yuan. The funds will come from internal resources and self-raised funds (including special loans for stock increase).
Related Articles
DMALL (02586) spent HKD 3.0244 million on July 3 to repurchase 501,200 shares.
GREENTOWN SER (02869) spent approximately HKD 1.9812 million on July 3rd to buy back 492,000 shares.
CNNC INT'L(02302) affiliated received a non-committed loan with an amount not exceeding 30 million US dollars.
DMALL (02586) spent HKD 3.0244 million on July 3 to repurchase 501,200 shares.
GREENTOWN SER (02869) spent approximately HKD 1.9812 million on July 3rd to buy back 492,000 shares.
CNNC INT'L(02302) affiliated received a non-committed loan with an amount not exceeding 30 million US dollars.
RECOMMEND
